SCHEMBL20814652

SCHEMBL20814652

O=C(COCC(=O)Nc1c(Cl)cccc1C(=O)O)NCc1cccc(-c2ccco2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.54
UBE2I P63279 4/20 0.45
SAE1 Q9UBE0 4/20 0.45
UBA2 Q9UBT2 4/20 0.45
CACNA1B Q00975 3/20 0.45
APBA1 Q02410 3/20 0.45
PRMT6 Q96LA8 1/20 0.42
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
PLA2G1B P04054 2/20 0.39
ATG4B Q9Y4P1 2/20 0.39
HTT P42858 1/20 0.39
KEAP1 Q14145 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17530197 0.85 SERPINE1 (0.50) SERPINE1PRMT6KMT2AMEN1ALDH1A1
SCHEMBL1015171 0.84 SERPINE1 (0.75) SERPINE1UBE2ISAE1UBA2CACNA1B
SCHEMBL1015337 0.78 SERPINE1 (0.62) SERPINE1UBE2ISAE1UBA2CACNA1B
SCHEMBL1016073 0.71 SERPINE1 (0.72) SERPINE1PRMT6KMT2AMEN1POLB
SCHEMBL1014818 0.70 SERPINE1 (0.56) SERPINE1KMT2AKDM4EALDH1A1POLB
SCHEMBL10242930 0.70 PRMT6 (0.60) PRMT6KMT2AKDM4EMEN1ALDH1A1
SCHEMBL1014985 0.70 SERPINE1 (1.00) SERPINE1KDM4EPOLBMAPTL3MBTL1
SCHEMBL17530198 0.67 SERPINE1 (0.47) SERPINE1UBE2ISAE1UBA2CACNA1B
SCHEMBL10243163 0.67 PRMT6 (0.59) PRMT6KMT2AKDM4EMEN1ALDH1A1
SCHEMBL20814651 0.67 SERPINE1 (0.56) SERPINE1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990057-B1 PAI-1 INHIBITOR FOR USE IN ENHANCING THE ANTITUMOR EFFECT OF AN ANTITUMOR AGENT IN A PATIENT RENASCIENCE CO LTD (JP) 2019-03-20 EP disclosed